


Why self-management is key to a better life for heart failure patients

Putting patients at the heart of heart failure services

British IRONMAN Trial Published

MPs more interested in potholes than heart failure

Empagliflozin

UK Heart Failure Patient Charter

Living well with Heart Failure report 2022

DAPAGLIFLOZIN ACCEPTED FOR USE WITHIN NHS SCOTLAND

Legal right to 2 week review of patients with suspected heart failure (HF)

NICE Impact Report Cardiovascular Disease Management

NICE Recommends Dapagliflozin for Heart Failure
NICE in the UK recommends Dapagliflozin (FORXIGA) to treat heart failure with reduced ejection fraction for patients with or without Diabetes.

Heart failure and Covid-19 Statement

Heart Failure Marvellous Award Winners 2021 for their outstanding contribution
